BioCryst Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript
Welcome to day two of RBC's Annual Healthcare Conference. I'm Brian Abrahams, one of the senior biotech analysts here. Really pleased to have our first company this morning, BioCryst Pharmaceuticals, represented by their President and CEO, Jon Stonehouse. Jon, thanks so much for joining us.
Yeah, thanks for having us.
Questions & Answers
Great. So I wanted to start big picture on the HAE market. Can you tell us a little bit more about what you've learned since the Orladeyo launch about what the treatment paradigm and market dynamics look like here? I guess I'm curious if there are still HAE patients out there who may not yet be plugged into an allergist or maybe who are engaged with a specialist but are not on prophylactic therapy. What you guys are doing to identify patients, help them switch off of existing medications, and also help them engage
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |